Cardiovascular risk factors in minorities.
Recent clinical trials have confirmed the value of intervention on major risk factors, particularly hypertension and hyperlipidemia, in preventing the progression and clinical sequelae of atherosclerosis. Less is known about the prevalence and impact of atherosclerosis risk factors in minorities. A review of recent literature reporting the prevalence of established and new predictors of atherosclerotic events in minority populations and the inclusion of minorities in clinical trials is presented. The prevalence of risk factors differs considerably in minority populations. The role of "premature" coronary death and the level of some risk factors, particularly obesity and blood pressure in African descendants and high triglycerides, low high-density lipoproteins, and diabetes in some Hispanics, is higher than in whites. With few exceptions, however, minorities have not been included in clinical trials in sufficient numbers to determine whether significant differences in the benefit of risk factor intervention exists. Prevalence of key risk factors differs among minority groups. Risk factor intervention should be pursued in minority groups but with the understanding that clinical trials have not ruled out the possibility of qualitative or quantitative differences in response rates among different groups.
LaRosa
John C
JC
Office of the President, SUNY Downstate Medical Center, Brooklyn, NY 11203-2098, USA. jclarosa@downstate.edu
Brown
Clinton D
CD
D002318:Cardiovascular Diseases / Q000208:ethnology* / Q000209:etiology*; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D008913:Minority Groups; D009765:Obesity / Q000150:complications; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects